Showing 1 - 7 results of 7 for search 'Andrea Szegedi', query time: 0.02s Refine Results
  1. 1
    The use of mineralocorticoid antagonists in chronic heart failure

    The use of mineralocorticoid antagonists in chronic heart failure by Andrea Szegedi, Nóra Homoródi, Attila Borbély

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Recreation and heart diseases: aviation and wellness

    Recreation and heart diseases: aviation and wellness by Nóra Homoródi, Andrea Szegedi, Tímea Bianka Papp, Szabolcs Gergely, Zoltán Csanádi

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation

    The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation by Petra Molnár, Máté Ágoston Demény, Beáta Várkonyi, Beáta Várkonyi, Zsuzsanna Polgár, Ágnes Pór, Ilona Kovács, Andrea Szegedi, Andrea Szegedi, Attila Gábor Szöllősi, Attila Gábor Szöllősi, Magdolna Szántó

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Genome wide analysis of TLR1/2- and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands.

    Genome wide analysis of TLR1/2- and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands. by Dániel Törőcsik, Dóra Kovács, Szilárd Póliska, Zita Szentkereszty-Kovács, Marianna Lovászi, Katalin Hegyi, Andrea Szegedi, Christos C Zouboulis, Mona Ståhle

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype

    Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype by Dorottya Horváth, Dorottya Horváth, Zsófia Pénzes, Zsófia Pénzes, Petra Molnár, Petra Molnár, István Rebenku, György Vereb, György Vereb, György Vereb, Magdolna Szántó, Szabolcs Muzsai, Szabolcs Muzsai, Andrea Szegedi, Andrea Szegedi, Zsolt Dajnoki, Zsolt Dajnoki, Kitti Pázmándi, Tünde Fekete, Attila Bácsi, Attila Bácsi, Attila Gábor Szöllősi, Attila Gábor Szöllősi

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

    Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational... by Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

    Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 ... by Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: